Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir [Paxlovid] in Patients with COVID-19
Sonu Abraham et al. Nirmatrelvir-ritonavir (NMVr) is used to treat symptomatic, nonhospitalized patients with coronavirus disease-2019 (COVID-19) who are at high risk of progression to severe disease. Patients with cardiovascular risk factors and cardiovascular disease are at a high risk of developing adverse events from COVID-19 and as a result have a higher likelihood of […]
PaxlovidTM – Making an Informed Decision
Canadian Covid Care Alliance In January 2022, Health Canada approved the use of the oral antiviral medication called PAXLOVIDTM. PAXLOVIDTM is made of a combination of two medications: nirmatrelvir and ritonavir. As with any medication, there are a number of key questions that healthcare practitioners can and do use to help determine if it is […]
Pfizer Annual Revenue Doubled – to $81.3 Billion – Thanks to COVID Vaccines
Joseph Mercola The COVID-19 pandemic has been a real boon to Pfizer. Not only has it doubled Pfizer’s annual revenue, but it has also given the drugmaker unique weight in determining U.S. health policy … Pfizer’s COVID jab dominates 70% of the U.S. and European markets, and Paxlovid, its COVID drug, has become a standard […]
Pfizer Asks Court to Dismiss Whistleblower Lawsuit Because Government Was Aware of Fraud
Michael Nevradakis A lawsuit led by whistleblower Brook Jackson alleging Pfizer and two of its contractors manipulated data and committed other acts of fraud during Pfizer’s COVID-19 clinical trials is paused following a motion by the defendants to dismiss the case. … Pfizer is a federal contractor because it signed multiple contracts with the U.S. […]
